rs201263014
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017433.5(MYO3A):c.3747T>A(p.Asn1249Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,611,536 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_017433.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO3A | NM_017433.5 | c.3747T>A | p.Asn1249Lys | missense_variant | 30/35 | ENST00000642920.2 | NP_059129.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO3A | ENST00000642920.2 | c.3747T>A | p.Asn1249Lys | missense_variant | 30/35 | NM_017433.5 | ENSP00000495965 | P1 | ||
MYO3A | ENST00000543632.5 | c.1777-37832T>A | intron_variant | 1 | ENSP00000445909 | |||||
MYO3A | ENST00000647478.1 | c.*1393+3472T>A | intron_variant, NMD_transcript_variant | ENSP00000493932 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152028Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000643 AC: 16AN: 248708Hom.: 0 AF XY: 0.000112 AC XY: 15AN XY: 134526
GnomAD4 exome AF: 0.0000206 AC: 30AN: 1459390Hom.: 0 Cov.: 53 AF XY: 0.0000303 AC XY: 22AN XY: 725980
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 26, 2017 | Variant classified as Uncertain Significance - Favor Benign. The p.Asn1249Lys va riant in MYO3A has not been previously reported in individuals with hearing loss , but has been identified in 0.1% (19/18708) of East Asian chromosomes by the Ge nome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs201 263014). Although this variant has been seen in the general population, its freq uency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analyses suggest that this variant may not impact the pr otein, though this information is not predictive enough to rule out pathogenicit y. In summary, while the clinical significance of the p.Asn1249Lys variant is un certain, these data suggest that it is more likely to be benign. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 29, 2022 | The c.3747T>A (p.N1249K) alteration is located in exon 30 (coding exon 28) of the MYO3A gene. This alteration results from a T to A substitution at nucleotide position 3747, causing the asparagine (N) at amino acid position 1249 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at